LidoPatch Pain Relief Patch recalled over manufacturing violations
- Recall date
- May 19, 2020
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Wuhan Bingbing Pharmaceutical Co., Ltd. recalls LidoPatch (lidocaine HCl 3.6%, menthol 1.25%) Pain Relief Patch, packaged in 1 patch/box (NDC 10882-527-01); 30 patches…
- Recall number
- D-1277-2020
- FDA classification
- Class II
- Brand / firm
- Wuhan Bingbing Pharmaceutical Co., Ltd.
- Sold / distributed
- Nationwide in the USA
Why it was recalled
CGMP Deviations: due to the loss of product manufacturing records and retain product samples, there is no assurance that the product will remain within specification through the labeled expiration date.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
LidoPatch (lidocaine HCl 3.6%, menthol 1.25%) Pain Relief Patch, packaged in 1 patch/box (NDC 10882-527-01); 30 patches/box (NDC 10882-527-02 and 10882-527-04), Manufactured for: JAR Laboratories, Elmhurst, IL.
Get recall alerts
Free email alert whenever Wuhan Bingbing Pharmaceutical Co., Ltd. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Wuhan Bingbing Pharmaceutical Co., Ltd.